Jon turned 60 this week, which had him asking: “Can I live longer?” So we’re talking with Celine Halioua, the founder and CEO of Loyal, a biotech start-up with a mission to extend a dog’s lifespan. She believes that if they’re successful, it could work on humans too. Jon and Celine talk about Silicon Valley culture and ask the big tech question: Just because we can do something, should we? Plus, writers Kasaun Wilson and Alexa Loftus discuss the latest Twitter happenings, and Jon gives them a fashion show—which is great content for a podcast. The first half of Season 2 is streaming now on Apple TV+.CREDITSHosted by: Jon Stewart Featuring, in order of appearance: Kasaun Wilson, Alexa Loftus, Celine Halioua Executive Produced by Jon Stewart, Brinda Adhikari, James Dixon, Chris McShane, and Richard PleplerLead Producer: Sophie EricksonProducers: Zach Goldbaum, Caity GrayAssoc. Producer: Andrea Betanzos Sound Engineer & Editor: Miguel CarrascalSenior Digital Producer: Freddie MorganDigital Coordinator: Norma HernandezSupervising Producer: Lorrie BaranekHead Writer: Kris Acimovic Elements: Kenneth Hull, Daniella PhilipsonTalent: Brittany Mehmedovic, Marjorie McCurry, Lukas Thimm Research: Susan Helvenston, Andy Crystal, Cassie MurdochTheme Music by: Gary Clark Jr. The Problem with Jon Stewart podcast is an Apple TV+ podcast, produced by Busboy Productionshttps://apple.co/-JonStewart
The podcast briefly discusses the idea of longevity pills that could help humans and dogs live longer and how ridiculous the concept may seem.
In this episode, the guest discusses the fear of aging and the desire to live longer and healthier lives. They also touch on the current events surrounding celebrities such as Kanye West and Elon Musk.
Podcast hosts discuss Elon Musk's recent comments regarding free speech on Twitter and manipulation tactics used by individuals on social media.
Loyal is a biotech startup developing drugs to increase the health span of dogs, aiming to improve the quality of life for beloved pets. The CEO and founder, Celine Halioua, was inspired to pursue this endeavor after interning with terminal patients as a teenager.
In this episode, Markita Landry explains how their research helps us understand the ways we age unhealthily over time and lead to age-related diseases.
Dr. David Sinclair discusses the challenge in developing drugs for aging, as people live for a long time and it would take decades to know the efficacy of a drug. He instead turns to studying the genetics of dogs to better understand aging and longevity.
A biotech company is developing a drug to help increase the lifespan of dogs by correcting the genetic consequences of breeding bigger dogs. Promising results have already been found, with dogs treated with the drug showing positive impacts on age-related diseases.
The speaker reflects on the warnings around artificial intelligence and how it relates to the idea of aging drugs and extending lifespan, and emphasizes the importance of working on things that help push forward humanity.
The process of getting aging pills approved by the FDA is complicated and expensive, but it's important to ensure that the products are safe and effective for the consumer.
The speaker discusses their work developing a drug that they believe will extend health spans and quality of life in dogs and potentially lead to lifespan extension. They are currently working with the FDA to conduct a study on the drug's efficacy.
The speaker criticized the lavish accumulation of wealth and power by tech figures and compared the existence of wealth beyond monarchs to the FTX and Vanderbuilts.
Join us for a sound journey of repeated syllables as we explore the power of rhythm and repetition in meditation and mindfulness.